FILE - A supermoon rises through clouds over the skyline of lower Manhattan, Aug. 1, 2023, as seen from West Orange, N.J. Stargazers are in for a double treat on Wednesday night, Aug. 30: a rare blue supermoon with Saturn peeking from behind. The cosmic curtain rises Wednesday night with the second full moon of August, the reason it’s considered blue. It’s dubbed a supermoon because it’s closer to Earth than usual, appearing especially big and bright. (AP Photo/Seth Wenig, File)
By Marcia Dunn
Stargazers are in for a double treat on Aug. 30: a rare blue supermoon with Saturn peeking from behind.
The cosmic curtain rises Wednesday night with the second full moon of the month, the reason it’s considered blue. It’s dubbed a supermoon because it’s closer to Earth than usual, appearing especially big and bright.
This will be the closest full moon of the year, just 222,043 miles (357,344 kilometers) or so away. That’s more than 100 miles (160 kilometers) closer than the Aug. 1 supermoon.
As a bonus, Saturn will be visible as a bright point 5 degrees to the upper right of the moon at sunset in the east-southeastern sky, according to NASA. The ringed planet will appear to circle clockwise around the moon as the night wears on.
If you missed the month’s first spectacle, better catch this one. There won’t be another blue supermoon until 2037, according to Italian astronomer Gianluca Masi, founder of the Virtual Telescope Project.
Clouds spoiled Masi's attempt to livestream the supermoon rising earlier this month. He’s hoping for clearer skies this time so he can capture the blue supermoon shining above St. Peter’s Basilica at the Vatican.
Weather permitting, observers don’t need binoculars or telescopes — “just their own eyes." said Masi.
“I’m always excited to admire the beauty of the night sky,” he said, especially when it features a blue supermoon.
The first supermoon of 2023 was in July. The fourth and last will be in September.
A subvariant of the omicron COVID-19 variant called BA.2 is causing an outbreak overseas. Now, some health experts worry it could also lead to an increase in COVID-19 cases in the U.S. Dr. Amesh Adalja, infectious disease specialist and senior scholar at Johns Hopkins Center for Health Security, joins Cheddar News to discuss.
Dr. Alan Kaplin, Chief Scientific Officer of MyMD, joins Cheddar Innovates to discuss how the MYMD-1 is on track to be the first FDA-approved drug to treat aging and age-related diseases.
Tyler Hayes, CEO of Atom Limbs, joins Cheddar Innovates to discuss how the Atom Touch prosthetic is different from other prosthetics on the market, and how the Atom Limbs team of former Apple and Tesla leaders are bringing innovation into this industry.
Nouveau Monde Graphite says it wants to power the sustainable energy revolution. The Canadian company is developing carbon-neutral battery materials to serve the growing EV and cleantech markets and is doing so via a mining and manufacturing operation in Quebec. Eric Desaulniers, founder, president & CEO of Nouveau Monde Graphite, joins Cheddar News' Closing Bell to discuss.
Health experts are warning an even more contagious subvariant of Omicron, known as BA.2, could soon lead to another surge in Covid cases here in the U.S. The variant has already driven cases to skyrocket in China and Europe, which has historically served as a preview to the pattern the U.S. has seen throughout the pandemic. This comes at a time when protection from booster shots is waning for most people who got them. Dr. Jen Caudle, Family Physician & Associate Professor at Rowan University, explains what we can do to protect ourselves against the new variant and how we should act as warnings of another surge rise.
Catching you up on what you need to know Mar 24, 2022, with NATO meeting updates, Ukraine retaking suburbs around Kyiv, the spread of omicron subvariant BA.2 in China, Google Pay launching a third-party billing option, and a 16-year-old is suspected of being the Lapsus$ mastermind behind hacks of Microsoft and others.
Cannabis producer Cresco Labs is acquiring rival Columbia Care in a $2 billion all-stock deal, creating the largest U.S. cannabis company by sales. The deal, which is expected to close in the fourth quarter of 2022, is one of the biggest in the industry's history and would make Cresco the dominant player in a market projected to reach $46 billion in revenue by 2026. Charlie Bachtell, CEO of Cresco Labs, joins Cheddar News' Closing Bell to discuss.
Moderna announced it's seeking emergency use approval for its COVID-19 vaccine from the FDA for children under 6 years old. A former FDA associate commissioner and the president and co-founder of the Center for Medicine in the Public Interest (CMPI) Peter Pitts joined Cheddar News to talk about the timeline, benefits, and risks that come with the approval of the vaccine. "We want to protect their parents and their grandparents and their caregivers and their daycare providers, so it's all about protecting not just the kids but all around the people that are surrounding those kids," he said.
Moderna says its COVID-19 vaccine works in babies, toddlers and preschoolers. The company announced early findings Wednesday from a study of children younger than 6.
Catching you up on what you Need to Know on Mar 23, 2022, as NATO meets in Brussels to discuss Ukraine, mortgage rates rise, Justin Trudeau is set to lead Canada until 2025, tornadoes sweep through Louisiana, California may do away with SATs, and a Starbucks in Seattle unionizes.
